glofitamab,epcoritamab,axicabtagene ciloleucel,tisagenlecleucel,Lisocabtagene Maraleucel
Roche,genmab,abbvie,gilead,novartis,bms
['lymsm']
dr. sehn: not fair to compare car to bite head to head as they studied different patients. bite more heavily pretx, more primary refractory, more already with pd thru prior car. and pfs curves between car and bite don't look that much different. #lymsm #17icml 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈